Search This Blog

Wednesday, May 6, 2020

Heron Therapeutics EPS beats by $0.08, beats on revenue

Heron Therapeutics (NASDAQ:HRTX): Q1 GAAP EPS of -$0.57 beats by $0.08.
Revenue of $25.4M (-19.6% Y/Y) beats by $4.17M.
https://seekingalpha.com/news/3570088-heron-therapeutics-eps-beats-0_08-beats-on-revenue

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.